Opioid use after eye surgery correlates to new, persistent use in previously opioid-naïve patients

An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.

5:00 AM

Author | Jordyn Imhoff

drawing in blue ink on lined paper of eye with lab note badge written out in yellow and navy blue bottom right corner
Michigan Medicine

A retrospective claims-based cohort analysis of more than 300,000 opioid-naïve patients before ophthalmic surgery between 2012 and 2017 found that exposure to opioids after their surgery was linked to new, persistent use long term.

The analysis, published in Ophthalmology, suggests that patients who had never used opioids before surgery are at higher risk of addiction post-surgery, making exposure to opioids an independent risk factor for persistent use in this group of patients. Persistent use is defined as filling a prescription 90 days after surgery, and then again in the 91-180-day post-operation period. 

"Patients and their families can be impacted if opioids given for post-surgical pain are misused. My initial research interest was in over-prescribing of opioids after corneal procedures," said Maria Woodward, M.D., M.S., lead author of the study and an ophthalmologist at University of Michigan Health Kellogg Eye Center.

Although there's data on who is prescribed opioids after surgery, less is known about the long term effects of these short-term prescriptions.

"Prescribing these medications should be carefully considered by the treating physician. We should share the responsibility with the patients to consider the necessity of an opioid prescription," said Woodward, also a member of the University of Michigan Institute for Healthcare Policy and Innovation. "From a policy standpoint, best practices for prescribing these medications should be developed."

The American Academy of Ophthalmology has created a webpage of safe, opioid prescribing resources for physicians, but not all hospitals may know they can access these, or that they can use this guidance to inspire their own best practices at their respective institutions.

"Clinicians that are prescribing opioids should consider if they've given adequate warning about the dangers of the medication to the patient, taking into consideration their individual pain threshold and history of opioid use," said Woodward. "Are there other pain management options that are better suited for the patient to match the level of pain with the prescribed medication?"

Next steps for Woodward's research team includes studying the barriers that providers face at their institutions to creating best practices for prescribing opioids and tailoring pain prescriptions, so the national opioid crisis can start to be combatted at the foundational level.

Financial Support: This study was funded by the National Eye Institute (R01EY031033), Research to Prevent Blindness and the Career Advancement Award, the Vitreo-Retinal Surgery Foundation Award, American College of Surgeons and the American Foundation for Surgery of the Hand, Centers for Disease Control and Prevention (E20182818-00), Michigan Department of Health and Human Services (E20180672-00), National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50 AR070600), National Institute on Drug Abuse (RO1 DA042859), Substance Abuse and Mental Health Administration (E20180568-000), and the University of Michigan School Dean's Office—Michigan Genomics Initiative and Precision Health Initiative.

Paper Cited: "Persistent Opioid Use after Ophthalmic Surgery in Opioid-Naive Patients and Associated Risk Factors," Ophthalmology. DOI: 10.1016/j.ophtha.2021.04.021


More Articles About: Lab Notes Addiction and Substance Abuse Basic Science and Laboratory Research Eye Care & Vision Health Care Delivery, Policy and Economics Kellogg Eye Center Patient Safety Pain management Drug Abuse and Misuse Medication Guidelines Surgery Types Post Operative and Recovery All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Jianping Fu, Ph.D., Professor of Mechanical Engineering at the University of Michigan and the corresponding author of the paper being published at Nature discusses his team’s work in their lab with Jeyoon Bok, Ph.D. candidate at the Department of Mechanical Engineering.
Health Lab
Human stem cells coaxed to mimic the very early central nervous system
The first organized stem cell culture model that resembles all three sections of the embryonic brain and spinal cord could shed light on developmental brain diseases
Graphic showing pills, a heart and brain with data on aspirin use
Health Lab
Aspirin can prevent a second heart attack or stroke, but many don’t use it
Washington University School of Medicine and Michigan Medicine researchers found that fewer than half of people who have experienced a heart attack or stroke use aspirin to prevent a second one.
Illustration of girl with blue water line, depicting a figure drowning, as girl contemplates pill in hand
Health Lab
Antidepressant dispensing to adolescents and young adults surges during pandemic
Rate of antidepressant dispensing to young people rose faster after March 2020, especially among females
Scale pictured behind a hospital room curtain
Health Lab
Obesity care can make a big difference, but few get it, study suggests
Obesity care under a health care provider’s supervision, whether through nutrition counseling, medication, meal replacement or bariatric surgery, can help people with high BMI, but many don’t receive it.
Illustration of a microscope
Health Lab
Hippo signaling pathway gives new insight into systemic sclerosis
Study focuses on Hippo signaling pathway as critical link between fibrosis, vascular dysfunction, and sex bias in systemic sclerosis
Headshot of Anne Draelos
Research News
U-M's Anne Draelos named a 2024 Sloan Research Fellow in neuroscience
Anne Draelos, Ph.D., Assistant Professor of Biomedical Engineering and Computational Medicine & Bioinformatics, has been named a 2024 Sloan Research Fellow in Neuroscience.